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ABSTRACT 
Asthma is a chronic disease with recurrent breath shortness. Until now, there is no particular 
therapy to cure the disease and long-term treatment is needed to control the disease. Health insurance has 
the benefit to support the asthma therapy. This study aimed to assess the effect of health insurance on the 
asthma control based on Asthma Control Test (ACT) score. The study was done with a cross-sectional 
design on respondents with asthma who agreed to sign informed consent forms in Yogyakarta. The asthma 
respondents (n=36) were selected non-randomly, consisting of 23 respondents with health insurance, 
including universal health coverage or UHC (n=15), UHC and private insurance (n=7), and private 
insurance only (n=1). The ratio and categorical data were analyzed with the independent T-test or Mann-
Whitney test and chi-square statistics, respectively. The study demonstrated that the profiles and number of 
medicines were similar between groups, except for lower smoking proportion among health insurance 
groups; the respondents with and without health insurance had the median ACT score at 22 (partial 
control) and 15 (bad control) respectively, though the scores were not statistically different. Conclusion: 
the asthma respondents with and without health insurance were not statistically different in the asthma 
control. 
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ABSTRAK 
Asma merupakan penyakit kronis dengan gejala serangan sesak nafas berulang yang belum ada 
penyembuhannya, dengan demikian diperlukan penatalaksanaan terapi jangka panjang yang efektif dan 
aman. Asuransi kesehatan bermanfaat mendukung terapi pasien asma. Penelitian ini dilakukan dengan 
tujuan mengevaluasi pengaruh asuransi kesehatan terhadap pengendalian asma berdasarkan skor Asthma 
Contol Test (ACT). Penelitian observasional ini dilaksanakan dengan rancangan potong lintang pada 
responden di Provinsi Yogyakarta yang pernah atau sedang mengalami asma serta bersedia mengisi 
informed consent. Responden dipilih menggunakan metode sampling nonrandom. Dari 36 responden 
asma, sebanyak 23 responden memiliki asuransi kesehatan yang meliputi JKN-BPJS (n=15), JKN-BPJS 
dan asuransi swasta (n=7), dan hanya asuransi swasta (n=1). Data rasio dianalisis dengan uji-T atau 
Mann Whitney, sedangkan data kategorikal dianalisis menggunakan uji chi-square. Hasil penelitian 
menunjukkan karakteristik responden dan jumlah obat asma responden tidak berbeda kecuali faktor 
merokok dengan proporsi yang lebih sedikit secara bermakna pada responden yang memiliki asuransi 
kesehatan. Responden dengan asuransi kesehatan memiliki median skor-asma ACT 22 (terkendali 
sebagian) dibandingkan tanpa asuransi dengan skor ACT 15 (pengendalian yang buruk) meskipun secara 
statistik berbeda tidak bermakna. Kesimpulan: responden dengan dan tanpa asuransi kesehatan memiliki 
pengendalian asma yang berbeda tidak bermakna secara statistik.  
Kata kunci: asma, pengendalian asma, skor Asthma Control Test (ACT), asuransi kesehatan 
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INTRODUCTION 
Asthma, a major non-communicable disease, 
has the clinical characteristics of chronic 
inflammation in the respiratory tract and recurrent 
breath shortness (WHO, 2017a). The prevalence of 
asthma in Yogyakarta Province in 2013 was 6.9%, 
and the incidence was higher than national data at 
4.5% (BPDANP Kesehatan Kemenkes RI). The 
inflammation process in asthmatic patients 
involves increased numbers of cells and cell 
elements, including mast-cells, eosinophils, 
lymphocyte-T cells, macrophages, neutrophils, and 
epithelia cells. Until now, there are no primary 
cures nor prevention for asthma. Patients with 
asthma depend on a long-term asthma therapy, and 
they need therapy with efficacy and safety to 
control the disease or to prevent the exacerbations 
(Kelly and Sorkness, 2008). Uncontrolled asthma 
will lead to the increase in mortality rate among 
the patients and the mortality rate due to asthma at 
80% happens in low and middle-low income 
countries (WHO, 2017b).  
Financial support for long-term therapy is 
one of the important factors to control the disease 
among the subjects. Patients are concerned about 
the affordability aspect of the medicine; therefore, 
they expect to be able to communicate with 
healthcare providers for more effective and 
efficient therapy (Patel and Wheeler, 2014). Lack 
of health access contributes to the increase of 
hospitalization and mortality rate in asthma 
patients (Kelly and Sorkness, 2008). A study of 
therapy cost showed that the health burden of 
asthma is likely to affect the therapy outcome of 
the disease. Children whose parents believe that 
asthma therapy is an economic burden will have 
more emergency visits to health care and school 
absence due to the disease (Patel et al., 2012). 
Health financing support including health 
insurance is considered as a solution for most 
disease control including asthma.  
Recently, the greatest health financing 
support system in Indonesia is the Universal 
Health Coverage (UHC) or according to the 
Indonesian terminology it is called as Jaminan 
Kesehatan Nasional. The UHC is managed by the 
social (health) insurance management agency or 
Badan Pengelola Jaminan Sosial (BPJS) 
Kesehatan with the principle of cooperation. Data 
in November 2017 indicated the UHC covered 
more than 183.5 million population and involved 
21,771 health facilities. The UHC has the target of 
100% coverage of the Indonesian population, and 
the UHC aims to support population welfare with 
qualified and continuous health care including for 
asthma patients. The UHC covers the management 
of asthma in the primary care and the secondary 
care (BPJS Kesehatan).  
Besides the health financing support, the 
patients’ knowledge contributes to asthma control. 
A cross-sectional study done in Cipto 
Mangunkusumo Hospital in Jakarta among 
uncontrolled asthmatic patients showed that 
patients’ knowledge was the most influential factor 
on treatment adherence, whereas the health 
insurance and other factors had an insignificant 
effect on the disease control (Ferlani et al., 2015). 
Poor asthma control causes depression, frequently 
found in geriatric patients, and decreases patient’s 
quality of life.  
The Asthma Control Test (ACT) is a tool to 
measure asthma control (American Thoracic 
Association, 2017; GSK, 2017). Some studies 
using ACT demonstrated the correlation between 
ACT score and asthma control. A longitudinal 
study done in 1-year duration showed the increase 
of asthma control was equal to the increase of 
ACT score (Afandi et al., 2013). Another study on 
occupational asthma patients showed that the 
patients have statistically and clinically worse 
ACT score at work than the ACT score outside the 
work (Quirce et al., 2013). 
Studies on the asthma control due to the 
disparity of health insurance in Yogyakarta 
population were not found during the literature 
review. Whereas, a study related to the health 
insurance in hypertension patients in Yogyakarta 
Province was found that showed patients with 
insurance had better awareness and higher therapy 
proportion than those without insurance. 
Nonetheless, the insurance was not successful to 
increase the blood pressure control (Suhadi et al., 
2015). Based on the above description, a study was 
done among the population in Yogyakarta to 
evaluate the effect of the insurance ownership, 
therapy, and respondent profiles on asthma control 
using ACT. 
 
METHODS 
This study was an observational research 
conducted with the cross-sectional design with the 
study permit No. 070/01008 issued by Dinas 
Penanaman Modal dan Perizinan Pemerintah 
Kota Yogyakarta. The study protocol was 
approved by The Ethics Commission of the 
Medical Faculty, Universitas Kristen Duta 
Wacana with the Ethical Clearance No. 
405/C.16/FK/2017. This study was part of the 
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main study about Improving the Role of the 
Indonesian Pharmacists on Asthma Management 
through “Pelayanan Kefarmasian Pasien Asma or 
PKPA” (Pharmaceutical Care on Asthma Patients). 
 
Selection of the Subjects 
The subjects were recruited from people 
who live in Yogyakarta Province. The inclusion 
criteria were those who were experiencing and/or 
recently suffered from asthma for both with or 
without routine therapy of asthma, and signed the 
informed consent for the willingness to participate 
in the study. The respondents were selected with 
non-proprietary sampling. Respondents were 
obtained from private clinics, hospitals, and 
community. Furthermore, some respondents were 
recommended by other respondents.   
 
Procedures 
The independent variable of the study was 
the ownership of health insurance for asthma 
therapy divided into the UHC, private/voluntary 
insurance, and without health insurance coverage, 
whereas the dependent variable was asthma 
control measured by ACT. Additional variables 
included sociodemographic profiles of age, 
gender, education background, and occupation; 
weight; medication history including non-
pharmacology; etiology and history of asthma.  
Data collection was done by direct interview 
guided with open-ended questionnaire. The 
interview appointment was done at the time and 
place agreed by the respondents. The data 
collectors consisted of the interviewer and the note 
documenter who guided the respondents in 
answering the questionnaires. All interviews were 
recorded with a voice recorder. The ACT score 
was measured using ACT in the Indonesian 
version (Zaini, 2011). The children respondents 
were accompanied by their parents during the 
interview. The questionnaires for the interview 
have been translated into the Indonesian language. 
All data collectors were trained for their reliability 
in understanding the questions and the 
respondents’ answers before the interview. 
 
Data Analysis 
The ACT scores were categorized based on 
clinical asthma outcomes into 3 levels, namely: 
uncontrolled asthma at ACT score less or equal to 
19, partially controlled asthma at ACT score 20-
24, and perfect controlled asthma at ACT score 25 
(Zaini, 2011). The data analysis was done both in 
total respondents and categorical groups (with and 
without health insurance). Categorical data 
included gender, family history, history of 
hospitalization due to asthma, routine visit to 
health care facilities were analyzed using chi-
square 2x2 statistics. Meanwhile, the smoking 
status of active, passive, and non-smoker was 
analyzed with Gamma test. The ratio data of age, 
age with the initiation of asthma, item of 
medicines administered by the respondents, and 
ACT score were analyzed for its distribution, 
followed by Mann-Whitney or T-test analysis 
depending on normal distribution of data. 
Statistical data analyses were done with 95% 
confidence level. The conclusions were drawn 
from both statistics and clinical outcomes.  
   
RESULTS AND DISCUSSION 
From 36 eligible asthma respondents, 23 
were covered with health insurance, namely UHC 
or JKN-BPJS (n=15), both UHC and private 
insurance (n=7), and private insurance only (n=1). 
The total of respondents in this study had more 
females than males, but the gender characteristics 
were similar between groups. This finding was 
similar to the asthma prevalence in adults which is 
higher in females (Kelly and Sorkness, 2008). 
Profiles of respondents between groups were not 
significantly different except for lower smoking 
status in respondents with insurance (p=0.03). 
(Table I).  
There were 4 respondents in the group with 
insurance making routine doctor visits for asthma 
therapy, whereas none from the without insurance 
group had this routine habit. In comparison, the 
routine therapy was not statistically different. This 
finding was similar with the result from a study 
that showed the effect of health insurance on the 
greater proportion of patients seeking chronic 
disease therapy in Sleman District of Yogyakarta 
Province (Suhadi et al., 2015). For the lower 
proportion of routine therapy among without 
insurance subjects, asthma will become health 
burden and they will likely have a poorer outcome 
in the future (Patel et al., 2012). Hospitalization 
due to asthma was not different between groups.
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Table I. Comparison of asthma respondent’s profiles in categorical data based on the ownership of  
health insurance/ financial support 
Characteristics Sub-group 
Ownership of health insurance/ financial support 
Yes 
n=23 
(proportion %) 
No 
n=13 
(proportion %) 
p value 
OR (95%CI) 
Gender 
 
Male 
Female 
6 (26.1) 
17 (73.9) 
3 (23.1) 
10 (76.9) 
0.84 
1.18(0.24-5.8) 
Visit to health care 
sites 
Routine 
Not-routine 
4 (17.4) 
19 (82.6) 
0 (0) 
13 (100.0) 
0,11 
n.a. 
Family History of 
asthma 
Yes 
No 
13 (56.5) 
10 (43.5) 
5 (38.5) 
8 (61.5) 
0.30 
2.08 (0.52-8.34) 
Hospitalized 
experience due to 
Asthma 
Yes 
No 
8 (34.8) 
15 (65.2) 
5 (38.5) 
8 (61.5) 
0.83 
0.85 (0.21-3.49) 
 
 
Smoking status 
Active 
Passive 
No 
0 (0.0) 
5 (21.7) 
18 (78.3) 
3 (8.3) 
4 (30.8) 
6 (46.2) 
0.03* 
 
Note: respondents with health insurance (n=23) including UHC or JKN-BPJS (n=15); UHC and private insurance 
(n=7); private insurance only (n=1); p-value with Chi-square; OR (95% CI) = odds ratio (95% confidence interval); 
*=gamma test; n.a.= not applicable cannot be calculated due to 0% in one group. 
 
 
Figure 1. Profiles of dosage forms of the medicine used 
by the total asthma respondents, groups with and 
without health insurance 
 
Respondents with health insurance had 
fewer smoking subjects than the without insurance 
subjects. The better smoking status was related to 
better awareness among the group with insurance. 
Smoking is an unfavorable factor for asthma 
control (Stapleton et al., 2011). Smoking status 
influenced the asthma control through the increase 
of anxiety and sensitivity among the asthma 
patients significantly (Avallone et al., 2015). 
Asthma has a close relationship with genetic 
factors or family history. Both groups of subjects 
had similar profiles for family history. Based on 
the ACT, both groups with and without insurance 
did not reach the ideal asthma control. This finding 
was likely related to smoking habit, both active 
and passive smoking, found in both groups of 
respondents. (Table II) Based on evidence-based 
medicine, it is crucial the smoking respondents 
become involved in the smoking cessation 
program for better asthma control (Saba et al., 
2014).  
Respondents in the groups of with and 
without health insurance were statistically similar 
in age, history of first asthma occurrence, items of 
asthma therapy, and ACT score. The ACT score 
indicates the asthma control, though the ACT 
score was not significantly different between 
groups, the respondents with insurance had ACT 
score at 22 (ACT 19-24) categorized as partial 
control of asthma. Meanwhile, the respondents 
without insurance had ACT score at 15 (ACT <19) 
categorized as poor control of asthma. Higher 
median ACT score among the respondents with 
insurance was related to the more frequent visits to 
health care center, therefore the appropriate 
therapy could prevent the asthma recurrence (Patel 
et al., 2012). 
Respondents in with and without insurance 
groups had the median value of 1 and 2 items of 
medicine, respectively. Respondents with 
insurance had higher median ACT score with 
fewer items of medicine (Table II). The better 
ACT score was also supported by more proportion 
of subjects with routine therapy. Knowledge level 
of the subjects was also considered as an important 
factor in asthma therapy (Ferlani et al., 2015) but 
this factor could not be evaluated in this study 
because the subjects were from a wide age range 
from youth to elderly and thereby, the knowledge 
level was difficult to measure. 
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Table II. Comparison of age profile, asthma history, ACT score, and item of medicine among the total asthma 
respondents and within the group with and without health insurance 
Characteristics 
Subjects with health insurance 
Yes  
n=23 
Mean ± SD (Median) 
No  
n=13 
Mean ± SD (Median) 
p-value* 
t-test  
(Mann-Whitney) 
Age (years) 31.0±17.5 
(27.0) 
35.0±19.0  
(27.0) 
0.53 
(0.67) 
Asthma history (at 
years) 
13.8±14.1 
(7.0) 
11.2±10.5  
(10.0) 
0.56 
(0.90) 
Item of medicine 1.7±1.0 
(1.0) 
2.2±1.3  
(2.0) 
0.28 
(0.26) 
ACT score 18.7±7.4 
(22.0) 
15.8±6.7  
(15.0) 
0.25 
(0.09) 
Note: ACT: Asthma Control Test; fixed combination medicine was calculated as 1 single item;  
*p-value between subjects with and without health insurance analyzed with T-test and Mann-Whitney due to not 
normally distribution of data. 
 
Drug selection was not further discussed 
in this study. The effect of drug selection and 
dosage form on the asthma control could not be 
evaluated in this study due to the variety of drug 
selection and limited subjects for each drug 
selection, furthermore some respondents did not 
recognize the composition of the medicine but 
they only knew the dosage form of the medicine 
used in the asthma therapy. The most frequently 
used dosage form of medicine in both with and 
without insurance groups was single oral 
preparation because oral single dosage form was 
more affordable (Figure 1). 
Limitation of the study 
The study showed the clinically better 
effect of the health insurance on ACT score. The 
result cannot be generalized to another population 
with different population setting because the 
baseline level of asthma severity of the 
respondents was not known. Asthma control is a 
result of multi-dimensions of patient, disease 
progress, medication, health-care provider, 
environment, and social background. The single 
factor of health insurance is likely not enough to 
affect the control of the disease. The study also has 
the limitation in the small number of respondents, 
therefore further research with more respondents is 
needed to confirm the results of the study.  
CONCLUSION 
The research of the asthma control in the 
respondents in Yogyakarta based on the ACT 
score can be concluded that the respondents with 
and without health insurance were not statistically 
different in asthma control.  
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